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ABSTRACT Demographic imbalance pyramids and strong growth of the population aged 
over 65 years are a serious challenge for the humankind [1,2,5,9] and the scientific community is 
called to respond to these challenges by maintaining the health of the elderly population to 
benefit from the positive role and experience that these people may have as emphasized also in 
the Healthy People 2020 program [4]. In this context, the development of bio-medical social 
programs for the elderly should be a priority of the government sector. In scientific terms is 
impetuous necessary to identify the relevant biomarkers of aging, to reveal biological targets 
upon which the medical act to be possible, resulting in a favorable adjustment of these 
mechanisms for decreasing aging rate, preventing the development of pathological processes or 
aging complications and giving individuals a positive social role [2].  
 
Currently, health is understood as 
the removal of diseases in a defensive 
manner to the pathological process and 
with higher costs. Would be more 
effective the maintenance of health 
through prevention mechanisms identified 
by modern science [2,6].  
The study of the mechanisms by 
which various natural or health factors can 
influence positively or negatively the 
aging process opens the path to design and 
obtain new products for the benefit of 
elderly people to maintain health for a 
long time and so to have socially active 
and positive role for others. Modern 
biotechnology allows today obtaining 
effective geroprotectors with medical use 
by which we can achieve the searched 
healthy-aging effect [2.12]. 
Analysis of numerous theories of 
aging  [2,3]  highlights several paradigm 
shifts of the researchers concerned with 
this area as a consequence of gradually 
scientific and technological development 
of the process [2]. Scientific research 
proposed for evaluation of the new 
therapeutic products will help to increase 
the knowledge in the field of geriatrics and 
gerontology, areas where Romania has 
played an essential role in the discovery of 
Gerovital by Professor Ana Aslan.  
If early theories of aging were 
centered at the level of organ dysfunction 
or systemic level of the body, the current 
theories see dysfunction of the cellular and 
molecular mechanisms [10]. Such modern 
approach reduced the differences between 
the existing theories on the mechanism of 
aging, emphasizing their complementary 
elements, but at the moment there is no 
integrative theory for post-reproductive 
ontogenetic development that can explain 
all the processes involved in the 
multiplicity aspects of aging [10] 
 Post-reproductive ontogenetic 
concept based on synergistic and 
antagonistic interactions of genetic and 
phylogenetic processes involved in 
reproduction and development involves a 
reorganization of the regulatory developed 
evolutionary processes and ensures the 
body adaptation to internal and external 
factors, after reproductive function 
consumption. Thus, correction and 
rescheduling particular functions comes as 
a compensation to loss or damage of other 
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processes with impact in the aging 
mechanism [2,3]. 
Aging is a degenerative process 
[11], extensively studied for which many 
theories have been formulated [10] which 
has as a target scheduled or non-scheduled 
nature [2,3,10,13, 44]. 
Programmed aging theories are 
subdivided into three conceptual 
subcategories  [2,13,14] genetically 
programmed longevity theory which 
assumes that aging is the result of starting 
or stopping certain genes being included 
the role of genetic instability (shortening 
of telomeres) in the dynamics of aging 
processes  [14, 17]; endocrine theory - 
according to which aging is governed by a 
biological clock whose function is 
regulated by endocrine mechanisms, 
including insulin-like growth hormone 
IGF-1 plays an essential role [2,3,14]; and 
immunity theory which states that the 
immune system can be programmed by a 
decrease in its functionality, 
immunosenescence, which will lead to 
increased susceptibility to infectious 
diseases, respectively aging [15,16,25,26].  
Theories which put the aging 
process due to internal and external 
environmental factors [10] are Wear and 
Tear Aging Theory according to which 
cells and tissues become aged over time 
[2,14]; vital level activity theory - which 
states that a high level basal metabolism 
leads to a shortening of the life of the 
organism  [2,14]; cross-linking theory 
presented by Bjorksten (1942) according 
to which the cumulative chemical 
interchange of important macromolecules, 
including collagen, causes aging  [2,14]; 
somatic DNA damage theory [47] which 
considers that aging results from genetic 
integrity degradation of somatic cell as a 
result of mutations registered both in the 
nucleus and in the mitochondria 
[2,13,14,44]; and free radicals theory 
which stipulates that the superoxide and 
other free radicals destroy the molecular 
components of cells and thus alter their 
normal function [11]. 
Reactive oxygen species (ROS) are 
probably the most significant free radicals 
with major implications in damage and 
cells and body aging [19,20]. Free radical 
theory is currently considered the  most 
acceptable explanation of aging [19], 
although recent data obtained on a set of 
transgenic mutant SOD2
 + / - or Mclk1 
+ / -  
mice disprove the central dogma of the 
theory [11]. In 1957 Harman proposed the 
idea that a general process of accumulation 
of oxygen free radicals negatively affects 
internal environmental factors and changes 
genetic factors, mechanism responsible for 
aging and death of all living things. The 
theory was revised in 1972 when was 
showed that mitochondria is the main 
center of some chemical reactions that 
generate free radicals.  
Considering the aging being a 
gradual loss of functional adjustment of 
some complex multifactorial biological 
processes, the individual genotype sure has 
an impact on the rate of aging. However, 
there are not identified genetic markers of 
the aging process, although in the last 20 
years, sustained efforts have been made 
[11,12,18]. 
Characterization of the rate of aging 
of the body employs the concept of 
biomarker of the aging [21,24,27], defined 
as quantitative or qualitative biological 
parameter that allows the prediction of 
functional status of the organism to a 
particular moment of its existence [22,24]. 
In this context, experts in the field suggest 
parameters that aim the age of nervous, 
cardiovascular, respiratory or excretory 
system and even advancing proposals for 
estimating the biological age of the cell. In 
humans, the biological age is surpassed by 
the psychological age, the intellectual age 
and the social age. 
Specific combination of some 
parameters considered biomarkers of the 
aging process and the use of refractive 
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index as optical parameter to assess the 
biological status of the body, mathematical 
interpretation of the data by using a 
patented analysis method for bioclinical 
informations previously developed by 
members of the research team, lead us to 
consider that the efforts to identify the 
optimal set of biomarkers will represent a 
landmark for scientific research in the 
gerontology area. 
Several authors have discussed the 
criteria for selection of some biomarkers 
of aging, emphasizing the following 
critical points that they should fulfill [23]: 
aging and longevity rate  prediction, 
quantitative monitoring the biological 
quality of the body by parameters by 
which the determination will not harm the 
integrity of the organism, the data obtained 
must be reproducible and comparable for 
different species of laboratory animals and 
with relevance for humans [23,25,27,28]. 
Among the main biological markers 
used to predict the biological age and 
longevity, the American Federation of 
Aging Research suggests as the set of 
biomarkers of aging [27]: systolic and 
diastolic blood pressure, the heart rate at 
rest, total cholesterol, HDL and LDL 
cholesterol, lipid levels, blood glucose, 
body mass index [26], abdominal obesity 
index, T lymphocytes level, cortisol level 
and electrocardiogram. 
Alostatic overstressing index [23] 
proposed by McEwen and Stellar 1993 
denotes the body's dysfunctional response 
to chronic stress and reveal increased 
levels of adrenaline, noradrenaline and 
dopamine hormones [2]. This index was 
used by Karlamangla and collaborators in 
a recent study of mortality in people aged 
over 70 years, pursued over a period of 4.5 
years. Patients with an alostatic 
overstressing increased index present a 
much higher risk of mortality. Thus, the 
study concludes that a uniform increase of 
alostatic overstressing index (normally 
located between -1.7 and 1.4) leads to an 
increase of 3.3 times in mortality 
measured in the range of 4.5 years. 
The so-called matrix protocol  [2] 
of aging biomarkers used by the 
International Institute of Longevity 
Montclair (New Jersey) determines the 
rate of aging on four levels: 
I.  the overall functionality of the 
body measured by the ratio of weight and 
level of fat, flexibility, aerobic endurance, 
bone density, tactile response latency, 
forced expiration volume, vision and 
hearing [27]; 
II. functioning at the cellular level 
monitored at the skin level by determining 
the cytoarchitecture changes of basal 
membrane, epidermal turn-over, sebaceous 
glands architecture, microvascular 
changes, collagen ratio, elasticity of the 
fibers [28]; 
III. the molecular level consider the 
growth and thyroid hormone level but also 
of coenzyme Q10, sensitivity to insulin, 
the heat shock proteins level, the 
oncogenes level in the blood, serum level 
of antioxidants [25]; 
IV.  at DNA level is studied the 
position and size of telomeres (set at WBC 
level) and the accumulation level of 
mutations in the genetic material. 
The researchers from the 
International Longevity Institute are 
currently working on a new laboratory 
chemistry test that should reflect the 
damage level of DNA and should bring 
science-based predictions regarding the 
therapeutic value of anti-aging 
interventions through the mutational 
changes occurring in the somatic genetic 
material [2, 28, 29]. 
Telomeres damage can be assessed 
indirectly by measuring some biomarkers 
that correlate with their shortening [28]. 
Thus, Jiang and Rudolph analyzed the 
telomeres shortening mechanism and the 
rate of aging in several organs and tissues, 
identifying four proteins whose expression 
increases in relation to telomere 
  123 
 Balneo Research Journal     DOI: http://dx.doi.org/10.12680/balneo.2013.1051     Vol.4, No.3, September 2013 
 
 
shortening, as these: Cathelcidines from 
macrophages and polymorphonuclear 
leukocytes lysosomes activated by 
bacterial infection; Chitinaza 3 like3 (Chi 
3L3) involved in the initiation of immune 
response; elongation factor 1α (EF-1 α) - 
which controls protein synthesis in human 
fibroblasts and Stathmins - which control 
the intracellular microtubules stability, cell 
motility and mitosis [2]. 
The concept of oxidative stress 
caused by free radicals or generation 
systems of such radicals in concentrations 
that exceed antioxidant defenses capacity, 
represents the basis of taking into account 
as biomarkers of aging, physiological and 
molecular indicators of oxidative stress. 
Carbonylate proteins represent, in this 
context, an example of the use of oxidative 
stress indicators as biomarkers of aging [2, 
25]. 
Many scientists consider the 
accumulation of carbonyls proteins in 
erythrocyte membrane as an indirect 
marker of aging and the ferro-reduction 
antioxidant potential (FRAP) in blood 
plasma as an indicator of the body's 
antioxidant defense capacity [2]. The 
oxidative and reductive activity of 
enzymes that act on glutathione, 
thioredoxin and other substrates of interest 
in the oxidation-reduction process reflects 
not only the level of antioxidative 
protection but are probably relevant 
biomarkers for aging rate. 
It has been suggested that 
microheteroplasmy could explain some of 
the pathological mechanisms related to 
aging such as diabetes, cardiovascular 
diseases, Parkinson, Alzheimer, cancer 
[2,23]. 
Mobile genetic elements (MGE) for 
whose description geneticist Barbara 
McClintock received the Nobel Prize in 
1983 have been proposed as components 
of genetic instability and on these 
considerations as factors of cellular 
senescence for many species, with effects 
that include impaired gene expression and 
age-related disorders in cell physiology, 
blocking cell growth and eventually cell 
death or blastic transformation. According 
to this hypothesis, aging is correlated at 
the cellular level with the trasposonic 
activity whereby a DNA sequence copy 
remains at its predetermined site in 
nucleus while the second copy, called 
transposon, can move to different locations 
in the genome [2]. 
NADH and FADH coenzymes - 
critical components of energetic transport 
in mitochondria may represent, by their 
expression level, biomarkers of 
mitochondrial activity and indirectly of 
senescence and body age. Their 
measurement can be made currently by 
polarizing microscopy techniques or by 
fluorescence [2]. 
Heat shock proteins (HSP) are other 
biomarkers of aging, and there are studies 
showing that the change of these proteins 
expression correlates with changes in 
longevity, experimentally described in 
Caenorhabditis elegans [2]. 
Apolipoproteins synthesized in the 
liver and intestine are involved in the 
transport of cholesterol and triglycerides in 
the blood, are considered more eloquent 
predictors of death by coronary heart 
disease  [23]. Particularly, apolipoprotein 
A1 that transports HDL cholesterol shows 
an inverse correlation with the risk of 
death by coronary heart disease, a high 
level being associated with a decreased 
risk while apolipoprotein B responsible for 
LDL-cholesterol transport has a direct 
correlation, the high level indicating a high 
risk of death. The ratio of the two 
apolipoproteins is, therefore, an influential 
indicator for the rate of aging [23]. 
Interleukin 6 - IL6 is a 
multifunctional cytokine that plays an 
essential role in acute inflammation stage. 
Although normally in the absence of 
inflammation can not be detected in blood 
samples over time by losing his regulation 
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expression, the expression level increases 
with age [22,23]. 
Growth hormone, secreted by the 
pituitary gland has a decreasing level with 
age of the body being registered a decrease 
by 14% every decade after the age of 20-
25 years and reaches half around the age 
of 60 [2, 21,22,26]. 
Measuring the refractive index of a 
biological sample [96] is a relevant optical 
parameter used in the diagnosis and 
treatment  [95], being an indicator of 
changes in the level of hydration, of the 
biological age of the sample or the level of 
intracellular dysfunction [93]. The 
refractive index measured in the serum of 
Wistar rats shows a time-dependence 
being measured an increase of 1,34136 
from birth to 1.35175 (250g) to adulthood 
[94]. The effective refractive index of a 
single cell [101] is determined by the 
refractive index of cellular constituents, 
and its determination provides us data on 
the size and volume of the cell, nucleus 
volume, setting of certain dysfunction at 
the cellular level [97,99,100]. 
Using the Kramers-Kronig relations 
allows quantifying time dependent 
changes of the refractive index starting 
from reflectance measurement of samples 
that can be made both in biological serum 
samples or culture medium [99] but also at 
the skin surface [98]. Therefore, we can 
consider as a biomarker of aging the 
refractive index of blood serum and in the 
skin and will correlate the application of 
the developed treatments in the project 
with the change of this index. 
Lifespan extension possibility was 
experimentally demonstrated for many 
geroprotector substances, including 
antioxidants  [75], latirogene, chelating 
agents  (carnosine  [53]), adaptogens, 
neurotropes, monoamine oxidase 
inhibitors, dehydroepiandrosterone, sexual 
hormones, growth hormone, melatonin 
[50], preparations from the pineal gland, 
protease inhibitors, antidiabetic agents, 
thymic hormones, immunomodulators, 
superoxide dismutase and catalase 
mimetics, enterosorbents, etc.. [47]. 
According to several authors, there are not 
geroprotectors with antiaging effect with 
unquestioned efficiency, scientifically 
proved, there are not a few cases of 
supposed geroprotector substances whose 
long term effects have proved difficult to 
predict initially [2]. 
In the past years, a new area of the 
gerontology becomes important, that of 
studying the so called HORMESIS 
mechanisms by which substances 
classified as toxic or very harmful, in 
subliminal doses, may have geroprotector 
effects, currently being numerous 
scientific investigations undertaken this 
regard [2, 35]. 
Reducing calorie intake has been 
shown experimentally to be a certain 
antiaging behavior [31,58]. Studying the 
mechanisms by which calorie intake 
reduction influences senescence and 
longevity rate in experimental animals 
[82], researchers have correlated this 
required behavior with reduce plasma 
levels of insulin [81], increase insulin 
receptor sensitivity, low body temperature, 
cholesterol, triglycerides, alpha-
lipoproteins, blood pressure and an 
increase in HDL cholesterol. Setting all 
these processes is experimentally 
correlated with the expression of some 
genes called sirtuins existing phylogenetic 
from yeast and to humans [39]. Sirtuins 
are enzymes such as deacetylase and ADP-
ribosyltransferase, whose name derived 
from  Saccharomyces cerevisiae, where 
they were discovered. In mammals sirtuins 
family consists of seven genes of this type, 
called Sirt1 to Sirt7. Recent researches 
seek to identify their role in cell 
physiology and mechanisms or molecular 
agents by which can be influenced their 
activity [31,32]. 
In 2011 there have been globally 
described 30 substances with geroprotector 
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properties, along side Gerovital - 
Romanian geroprotector product prepared 
by Prof. Ana Aslan in 1951, based on 
anesthetic procaine, noteworthy resveratrol 
and other polyphenols of plant origin [30], 
Rapamycin, antioxidants (vitamins A, C 
and E, carotenoids, lipoic acid, coenzyme 
Q, selenium, etc.), hormones (GH, thyroid 
hormones, adrenal and sexual hormones, 
melatonin  [50]), bioregulatory peptides 
(timalin, epithalmin), biguanides 
(metformin, fenformin)  [77], adaptogens 
(ginseng [48]). 
Sirolimus or rapamycin, described 
as immunosuppressive and antitumoral 
drug has been shown to be also an anti-
aging drug [41] whose goal is the TOR 
gene in yeast [43] and mTOR gene, its 
mammalian correspondent, also known as 
FK506 factor or FRAP1, a 
serine/threonine kinase that regulates cell 
growth, viability, mobility, protein 
synthesis and gene transcription [31,45, 
78]. Rapamycin, according to recent 
studies, may act preventively in 
atherosclerosis, hypertonia and 
hypercoagulation, thus preventing 
myocardial infarction, cardiovascular 
accidents, osteoporosis, cancer, 
autoimmune diseases, arthritis, fat 
diabetes, Alzheimer and Parkinson 
diseases [31,42,45]. 
Data from the specific literature 
shows that biguanides, particularly 
metformin  [56.77], used in the treatment 
of type 2 diabetes due to their ability to 
inhibit gluconeogenesis and to determine 
the increase of sensitivity to insulin may 
also have geroprotective effects [56]. 
2 deoxyglucose [78] is a glucose 
analog that absorbed by cells determine 
glucose inhibition resulting in decreased 
cellular energetic metabolism, situation 
that mimics calorie restriction. Data 
concerning the geroprotectection of this 
substance is not yet relevant. 
Antioxidants such as α-tocopherol, 
ascorbic acid, retinol, ubiquinone, 
selenium, as endogenous compounds or 
numerous synthetic molecules, intervene 
in gerossuppresion based on the aging free 
radical theory [87]. 
Resveratrol is the best known 
current geroprotector, discovered in 2003, 
present in high concentrations in the 
epicarp, seeds and stalk of grapes and 
subsequently in red wine [30,33], for 
which Romania is famous and is specified 
in collections, among other things, or in 
roots of Polygonum cuspidatum [2]. It is a 
natural phytoalexin used by certain plants 
in defense mechanism against pathogens 
such as bacteria and fungi, currently 
extensively studied, and that can influence 
the expression of sirtuins [35,37]. Since its 
discovery in 2003 until today there were 
registered worldwide over 2,000 
experimental studies on resveratrol, and 
there are laboratories focused on the study 
of this substance [2]. 
Preclinical studies on resveratrol 
demonstrated an increase in the longevity 
of S. cerevisiae of 70% by cultivation in a 
medium containing 10 mM resveratrol, of 
20% in C. elegans and 29% in Drosophila 
melanogaster by treatment with 100 mM 
resveratrol [39, 40]. 
In studies on laboratory mice, 
resveratrol at doses around 20 mg/kg 
caused a statistically significant decrease 
of age-related parameters such as 
albuminuria, the inflammatory level, 
vascular endothelial apoptosis, decreases 
in the elasticity of the aorta, the incidence 
of cataract, etc., being inclusively 
registered data towards the decrease of 
genetic instability [2]. 
On MRC5 human fibroblasts, the 
resveratrol in concentration of 5 µm 
induced a significant protection of DNA 
oxidative deterioration, preventing the 
growth of nuclear volume, reducing the 
generation of acetylated forms of H3 and 
H4 histones and p53 protein. In another 
study on human fibroblasts, using a 
concentration of 10 µm and 25 µm have 
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been obtained data supporting the delay in 
the morphological alterations at the 
cellular level correlated with age [2]. 
It is supposed that polyphenols such 
as resveratrol inhibits senescence at the 
cellular level by activating genes such as 
p53 and AKT [39], sirtuins or inhibition of 
others, like mTOR [46]. These influence 
different intracellular signaling pathways 
by which are controlled the expression of 
genes involved in cell growth, the 
proliferation and cell viability [34]. 
Clinical trials regarding resveratrol 
action in oncology that used a commercial 
form of resveratrol called SRT501 showed 
a 39% increase in apoptosis of malignant 
cells in patients with metastatic colorectal 
cancer [2]. 
Neuroprotective effects of 
resveratrol [30,35] have been described in 
experimental studies on laboratory mice 
and were explained by researchers by the 
effect of resveratrol of increasing the 
cysteine level that can protect cells from 
oxidative stress by regulating proteic 
precursors of amylase plate [38]. 
Resveratrol acts also on manganese 
superoxide dismutase (MnSOD) a group 
of enzymes that degrades metabolic 
generated superoxide molecules thus 
having antioxidant effect [80]. 
Cardioprotective effects of 
resveratrol  [30,36], as well as the other 
polyphenolic antioxidants such as 
quercetin or catechins, was observed in in 
vitro studies that showed a reduction of 
cardiomyocyte apoptosis by decreasing the 
level of caspase-3 and other cytokines, 
including NF-KB2, E-selectin, TNF-α or 
troponin [2]. 
Resveratrol also has an anti-
inflammatory effect [30,33], resulting in 
decreased activity of cyclo-oxygenase with 
a key role in the synthesis of other 
cytokines such as IL17. 
The theory of using antidiabetics 
like resveratrol [30] is explained by 
activating SIRT1 and subsequent increase 
in sensitivity to insulin [32], improving 
microcirculation and peripheral nerve 
function [2]. 
Resveratrol acts on the cellular 
mechanisms involved in photo-aging 
correlated with UV action, including MAP 
kinases, NF-kB nuclear factor and matrix 
metalloproteins. External applications of 
resveratrol in SKH-1 hairless mice model 
prior to UV exposure caused a significant 
reduction of cell proliferation, protection 
mRNA and phosphorylation [30]. 
The pharmacology of resveratrol 
[34] is still marked by a number of 
limitations, having a low solubility in 
water and consistently a low 
bioavailability and stability, being easily 
oxidized in the presence of light or heat. 
There are even data that contradict the fact 
that resveratrol would determine the extent 
of longevity, obtained on Drosophila 
melanogaster  and  C. elegans and 
disseminated by some authors [36]. 
Among the many hormones above 
mentioned with geroprotector effects [49], 
greater relevance for this project have the 
substances with similar actions of sexual 
hormones. Substances such estrogen like, 
testosterone like, which stimulate or 
inhibit various neuroendocrine 
mechanisms  [49]  are detected in the 
organic component of therapeutical muds 
and their geroprotective action is currently 
intensively studied. 
The testosterone serum level 
gradually decreases along with the 
advancing in age which caused a 
progressive muscle atrophy, fatigue, 
osteoporosis, reduced sexual function and 
increased fat levels, all this can be treated 
by administration of testosterone [22], 
which has as effect, in addition to a 
recovery of lipid levels also a decrease of  
concentration of plasma glucose correlated 
with increased sensitivity to insulin. 
The last half of the century allowed 
due to numerous scientific results, the use 
of estrogen in postmenopausal women to 
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prevent signs of aging, such as 
osteoporosis, cardiovascular diseases, 
decrease sexual and cognitive functions 
[52]. 
However, the enthusiasm was 
diminished by the recent publication of the 
results of some studies that show the risks 
of using estrogen, including breast cancer, 
pulmonary embolism, stroke and coronary 
heart disease. In this context, we can 
discuss by the importance of 
phytoestrogens and estrogen like 
substances from peloids composition 
whose effects does not reach the 
mentioned risks [2, 55]. 
Investigating the physiological 
effects of Procaine, an anesthetic 
[79,83,54] from Gerovital composition on 
bee neurons cultures, showed that this acts 
on Na
+  voltage- dependent channels or 
ligand-dependent channels [51]. 
 Procaine  has  known 
neuroprotective properties, preventing the 
formation of amyloid plaques and 
preserving ATP depletion, most likely by 
inhibiting neurotoxic effect of glutamate, 
like has been shown in PC12 rat cells 
cultures [76].  
Procaine is used in cardioplegia and 
in stabilizing the postischemic cardiac 
rhythm after the aortic decompression in 
cardiac surgery [84].  Anti-atherogenic 
effects of Gerovital and Aslavital were 
confirmed by recent studies regarding the 
LDL oxidation and inhibition of the 
generation of superoxide radicals, thus 
having antioxidant properties by which 
interfere with cellular and molecular 
mechanisms of aging [85,86]. 
The amount of procaine 
hydrochloride from Gerovital H3 - tablets / 
vials and Aslavital H3 - tablets / vial is 
100 mg plus 6 mg of the benzoic acid, 5 
mg of potassium metabisulfite and 0.5 mg 
biphasic sodium phosphate. The 
preventive treatment involves taking two 
tablets / day at 2-3 hours after meals, for 
12 days. The treatment is resumed after a 
break of one month. Parenteral the 
treatment is made 3 times/week for 4 
weeks. Treatment is resumed after a break 
of 1-2 months. A combination therapy is 
recommended - 4 weeks injection (12 
vials) 30 days break followed by a 12 days 
treatment with tablets. After 24 days, a 
new course of treatment can be started. 
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